1,3c1,14
< <!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3c.org/TR/1999/REC-html401-19991224/loose.dtd">
< <html xmlns="http://www.w3.org/1999/xhtml" xmlns:addthis="http://www.addthis.com/help/api-spec">
< <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="X-UA-Compatible" content="IE=7" /> 
---
>  
> 		
> 		
> 		 
> 	
>  
> 	<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3c.org/TR/1999/REC-html401-19991224/loose.dtd">
> <!--[if IE 7]>				 <html lang="en" class="no-js lt-ie9 lt-ie8"> <![endif]-->
> <!--[if IE 8]>				 <html lang="en" class="no-js lt-ie9"> <![endif]-->
> <!--[if IE 9]>				 <html lang="en" class="no-js lt-ie10"> <![endif]-->
> <!--[if gt IE 9]><!--> <html lang="en" class="no-js"> <!--<![endif]-->
> <html lang="en" xmlns="http://www.w3.org/1999/xhtml" xmlns:addthis="http://www.addthis.com/help/api-spec">
> <head><meta http-equiv="X-UA-Compatible" content="IE=7" />
> <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
28a40
> 	
30,40c42
< <script id="ssInfo" type="text/xml" warning="DO NOT MODIFY!">
<   <ssinfo>
<     <fragmentinstance  id="fragment23" fragmentid="FDAgov_Skip_Nav" library="server:SS_FRAG_FDAGOV_SKIPNAV"></fragmentinstance>
<   </ssinfo>
<   </script>
<  
<    
< 		
< 		
< 		 
<     <title>Table of Pharmacogenomic Biomarkers in Drug Labels</title> 
---
>       <title>Table of Pharmacogenomic Biomarkers in Drug Labeling</title> 
43c45
< 		<meta name="dc.title" content="Genomics - Table of Pharmacogenomic Biomarkers in Drug Labels"/>
---
> 	<meta name="dc.title" content="Genomics - Table of Pharmacogenomic Biomarkers in Drug Labeling"/>
54d55
< 	
60c61,62
< 	document.title = "Genomics" + " > " + "Table of Pharmacogenomic Biomarkers in Drug Labels";</script>
---
> 	document.title = "Genomics" + " > " + "Table of Pharmacogenomic Biomarkers in Drug Labeling";</script>
>  
62d63
< 
65,67c66,68
< <link rel="stylesheet" type="text/css" media="screen" href="/ucm/groups/fdagov-public/@system/documents/system/css_fda_gov_stylesheet.css" />
< <link rel="stylesheet" type="text/css" media="print" href="/ucm/groups/fdagov-public/@system/documents/system/css_fda_gov_print_stylesheet.css" />
< <!--[if lt IE 9]>
---
> 	<link rel="stylesheet" type="text/css" media="screen" href="/ucm/groups/fdagov-public/@system/documents/system/css_fda_gov_stylesheet.css" />
> 	<link rel="stylesheet" type="text/css" media="print" href="/ucm/groups/fdagov-public/@system/documents/system/css_fda_gov_print_stylesheet.css" />
> 	<!--[if lt IE 9]>
69,88c70,86
< <![endif]-->
< 
< 
< <!--- /**** Begin Sitewide JS References ****/-->
< <script type="text/javascript" src="http://ajax.googleapis.com/ajax/libs/jquery/1.4.2/jquery.min.js" ></script>
< <!-- ## ADDED tips Javascript reference to handle styling the tool tips ## -->
< <script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_tips.js"></script>
< 
< <script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_global.js"></script>
< <script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_resize.js"></script>
< <script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jqueryui/1.8.18/jquery-ui.min.js" ></script>
< <script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/highcharts.js" ></script>
<  <!-- ## ADDED hoverIntent JavaScript to support the drop-down menus ## -->
< <script type="text/JavaScript" src="/ucm/groups/fdagov-public/@system/documents/system/js_jquery_hover_intent.js"></script>
< <!-- ## ADDED submenus JavaScript reference to import code to handle displaying sub-menus when hovered over ## -->
< <script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_submenus.js"></script>
< <script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_jquery_tablesort.js"></script>
< 
<  
< 	<script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_jquery_tablepagination.js"></script> 
---
> 	<![endif]-->
> 	<!--- /**** Begin Sitewide JS References ****/-->
> 	<script type="text/javascript" src="http://ajax.googleapis.com/ajax/libs/jquery/1.4.2/jquery.min.js" ></script>
> 	<!-- ## ADDED tips Javascript reference to handle styling the tool tips ## -->
> 	<script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_tips_min.js"></script>
> 	<script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_global.js"></script>
> 	<script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_resize_min.js"></script>
> 	<script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jqueryui/1.8.18/jquery-ui.min.js" ></script>
> 	<script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/highcharts.js" ></script>
> 	<!-- ## ADDED hoverIntent JavaScript to support the drop-down menus ## -->
> 	<script type="text/JavaScript" src="/ucm/groups/fdagov-public/@system/documents/system/js_jquery_hover_intent_min.js"></script>
> 	<!-- ## ADDED submenus JavaScript reference to import code to handle displaying sub-menus when hovered over ## -->
> 	<script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_submenus_min.js"></script>
> 	<script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_jquery_tablesort_min.js"></script>
> 	 		
> 	<!-- ## For guidances dynamic list ## --> 
> 		<script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_jquery_tablepagination_min.js"></script> 
90,91c88
< 
< 		<!--- /**** FEATURE SECTION ****/-->	
---
> <!--- /**** FEATURE SECTION ****/-->	
97c94
< 	<script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_hovers.js"></script>
---
> 		<script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/js_fdagov_hovers.js"></script>
113,115c110
< <script type="text/javascript" src="https://www.google.com/jsapi"></script>
< <script type="text/javascript" src="/ucm/groups/fdagov-public/@system/documents/system/org.js"></script>
< 
---
>  
119,135c114,122
<  
<  <!--==== START nsharma: Combining SP_FDA_GOV_CONTENT_BOXES for all secondary pages under Fda Basics==== -->   
< <!--SS_BEGIN_SNIPPET(fragment23,1)--><div class="quicklinks"> 
<   <a href="#main" accesskey="2" class="quicklinks" tabindex="1" title="Skip to content">Quick Links: Skip to main page content</a>
<   <a href="#search-form" class="quicklinks" tabindex="1" title="Skip to search">Skip to Search</a>
< 
<   <a href="#fda-topmenu" class="quicklinks" tabindex="1" title="Skip to FDA top menu">Skip to Topics Menu</a>
< 		
< 		<a href="#section-menu" class="quicklinks" tabindex="1" title="Skip to Section table of contents">Skip to Section Content Menu</a>
<         
<   <a href="#footer-heading" class="quicklinks" tabindex="1" title="Skip to site options">Skip to Common Links</a>
< </div>
< 			<!--SS_END_SNIPPET(fragment23,1)-->
< 
<   <div id="outerwrapper">
<     		
< 		<!--==== BEGIN PAGE OUTER WRAPPER ==== -->
---
> 	<!--==== START nsharma: Combining SP_FDA_GOV_CONTENT_BOXES for all secondary pages under Fda Basics==== -->   
> 				
> 	<div class="quicklinks"> 
>   <a href="#main" accesskey="2" class="quicklinks" tabindex="1" title="Skip to content">Quick Links: Skip to main page content</a>
>   <a href="#search-form" class="quicklinks" tabindex="1" title="Skip to search">Skip to Search</a>
>   <a href="#fda-topmenu" class="quicklinks" tabindex="1" title="Skip to FDA top menu">Skip to Topics Menu</a>
> 	<a href="#section-menu" class="quicklinks" tabindex="1" title="Skip to Section table of contents">Skip to Section Content Menu</a>
> <a href="#footer-heading" class="quicklinks" tabindex="1" title="Skip to site options">Skip to Common Links</a>
> </div>
136a124,125
> <!--==== BEGIN PAGE OUTER WRAPPER ==== --> 
> 	<div id="outerwrapper">
159a149
> 			</MAXAMINEIGNORE>
163a154
> 					<MAXAMINEIGNORE XMLNS="FDA">
210,212c201,202
< 							<div id="masthead-links" style="margin-top:8px;">
< 								<a href="http://www.accessdata.fda.gov/scripts/search/index.cfm?action=archive.search" title="Search the FDA Archive">Search the FDA Archive</a>
< 							</div>
---
> 
> 
217c207
< 				</MAXAMINEIGNORE>
---
> 					</MAXAMINEIGNORE>
237,311c227,300
< <div id="content">
<       <div class="clearfloat"> </div>
<    
<       <div class="clearfloat"> </div>
< <!--==== BEGIN Topic Page Title ==== -->
< 
<             		
<             		<h1 id="topic_page_title" class="head1">Drugs</h1>
<             		
<             		
<             		
< <!--==== END Topic Page Title ==== -->
< 				<!-- ## ADD page-options ## -->
< 				<div id="page-options" class="hover-fade">
< 					<ul class="list-horizontal">
< 						<li><a href="javascript:window.print();" title="Print this page"><img src="/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_utility_icon_print.png" alt="Print"  title="Print this page"/></a></li>
< 						<li><a href="http://www.addthis.com/bookmark.php?u508=true&v=152&amp;username=fdamain" class="addthis_button_compact" title="Share this page"><img src="/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_utility_icon_share.png" alt="Share" title="Share this page"/></a></li>
< 						<li><a href="http://www.addthis.com/bookmark.php" class="addthis_button_email" title="E-mail this page"><img src="/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_utility_icon_email.png" alt="E-mail" title="E-mail this page"/></a></li>
< 						<!-- BEGIN esEspanol Button -->
< 							<script language="JavaScript" type="text/javascript">
< 							var MP = {
< 							<!-- mp_trans_disable_start --> 
<   							Version: '1.0.22',
<   							Domains: {'es':'esp.fda.gov'},	
<   							SrcLang: 'en',
< 							<!-- mp_trans_disable_end -->
<   							UrlLang: 'mp_js_current_lang',
<   							SrcUrl: unescape('mp_js_orgin_url'),
< 							<!-- mp_trans_disable_start --> 	
<   							init: function(){
<     							if (MP.UrlLang.indexOf('p_js_')==1) {
<       							MP.SrcUrl=window.top.document.location.href;
<       							MP.UrlLang=MP.SrcLang;
<   							}
< 							},
< 							getCookie: function(name){
<   							var start=document.cookie.indexOf(name+'=');
<   							if(start < 0) return null;
<   							start=start+name.length+1;
<   							var end=document.cookie.indexOf(';', start);
<   							if(end < 0) end=document.cookie.length;
<   							while (document.cookie.charAt(start)==' '){ start++; }
<   							return unescape(document.cookie.substring(start,end));
< 							},
< 							setCookie: function(name,value,path,domain){
<   							var cookie=name+'='+escape(value);
<   							if(path)cookie+='; path='+path;
<   							if(domain)cookie+='; domain='+domain;
<   							var now=new Date();
<   							now.setTime(now.getTime()+1000*60*60*24*365);
<   							cookie+='; expires='+now.toUTCString();
<   							document.cookie=cookie;
< 							},
< 							switchLanguage: function(lang){
<   							if(lang!=MP.SrcLang){
<     							var script=document.createElement('SCRIPT');
<     							script.src=location.protocol+'//'+MP.Domains[lang]+'/'+MP.SrcLang+lang+'/?1023749632;'+encodeURIComponent(MP.SrcUrl);
< 								document.body.appendChild(script);
<   							} else if(lang==MP.SrcLang && MP.UrlLang!=MP.SrcLang){
<     							var script=document.createElement('SCRIPT');
<     							script.src=location.protocol+'//'+MP.Domains[MP.UrlLang]+'/'+MP.SrcLang+MP.UrlLang+'/?1023749634;'+encodeURIComponent(location.href);
< 								document.body.appendChild(script);
<   							}
<   							return false;
< 							},
< 							switchToLang: function(url) {
<   							window.top.location.href=url; 
< 							}
< 							<!-- mp_trans_disable_end -->   
< 							};
< 							</script>
< 						<!-- END enEspanol Button -->
< 					</ul>
< 					
< 					<script type="text/javascript" src="http://s7.addthis.com/js/250/addthis_widget.js#pub=fdamain"></script>
---
> 	<div id="content">
> 		  <div class="clearfloat"> </div>
> 		  <div class="clearfloat"> </div>
> 	<!--==== BEGIN Topic Page Title ==== -->
> 	
> 						
> 						<h1 id="topic_page_title" class="head1">Drugs</h1>
> 						
> 						
> 						
> 	<!--==== END Topic Page Title ==== -->
> 					<!-- ## ADD page-options ## -->
> 					<div id="page-options" class="hover-fade">
> 						<ul class="list-horizontal">
> 							<li><a href="javascript:window.print();" title="Print this page"><img src="/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_utility_icon_print.png" alt="Print"  title="Print this page"/></a></li>
> 							<li><a href="http://www.addthis.com/bookmark.php?u508=true&v=152&amp;username=fdamain" class="addthis_button_compact" title="Share this page"><img src="/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_utility_icon_share.png" alt="Share" title="Share this page"/></a></li>
> 							<li><a href="http://www.addthis.com/bookmark.php" class="addthis_button_email" title="E-mail this page"><img src="/ucm/groups/fdagov-public/@system/documents/system/img_fdagov_utility_icon_email.png" alt="E-mail" title="E-mail this page"/></a></li>
> 							<!-- BEGIN esEspanol Button -->
> 								<script language="JavaScript" type="text/javascript">
> 								var MP = {
> 								<!-- mp_trans_disable_start --> 
> 								Version: '1.0.22',
> 								Domains: {'es':'esp.fda.gov'},	
> 								SrcLang: 'en',
> 								<!-- mp_trans_disable_end -->
> 								UrlLang: 'mp_js_current_lang',
> 								SrcUrl: unescape('mp_js_orgin_url'),
> 								<!-- mp_trans_disable_start --> 	
> 								init: function(){
> 									if (MP.UrlLang.indexOf('p_js_')==1) {
> 									MP.SrcUrl=window.top.document.location.href;
> 									MP.UrlLang=MP.SrcLang;
> 								}
> 								},
> 								getCookie: function(name){
> 								var start=document.cookie.indexOf(name+'=');
> 								if(start < 0) return null;
> 								start=start+name.length+1;
> 								var end=document.cookie.indexOf(';', start);
> 								if(end < 0) end=document.cookie.length;
> 								while (document.cookie.charAt(start)==' '){ start++; }
> 								return unescape(document.cookie.substring(start,end));
> 								},
> 								setCookie: function(name,value,path,domain){
> 								var cookie=name+'='+escape(value);
> 								if(path)cookie+='; path='+path;
> 								if(domain)cookie+='; domain='+domain;
> 								var now=new Date();
> 								now.setTime(now.getTime()+1000*60*60*24*365);
> 								cookie+='; expires='+now.toUTCString();
> 								document.cookie=cookie;
> 								},
> 								switchLanguage: function(lang){
> 								if(lang!=MP.SrcLang){
> 									var script=document.createElement('SCRIPT');
> 									script.src=location.protocol+'//'+MP.Domains[lang]+'/'+MP.SrcLang+lang+'/?1023749632;'+encodeURIComponent(MP.SrcUrl);
> 									document.body.appendChild(script);
> 								} else if(lang==MP.SrcLang && MP.UrlLang!=MP.SrcLang){
> 									var script=document.createElement('SCRIPT');
> 									script.src=location.protocol+'//'+MP.Domains[MP.UrlLang]+'/'+MP.SrcLang+MP.UrlLang+'/?1023749634;'+encodeURIComponent(location.href);
> 									document.body.appendChild(script);
> 								}
> 								return false;
> 								},
> 								switchToLang: function(url) {
> 								window.top.location.href=url; 
> 								}
> 								<!-- mp_trans_disable_end -->   
> 								};
> 								</script>
> 							<!-- END enEspanol Button -->
> 						</ul>
> 						
> 						<script type="text/javascript" src="http://s7.addthis.com/js/250/addthis_widget.js#pub=fdamain"></script>
313,319c302,308
< 					<script type="text/javascript">
< 					var addthis_config = {data_track_clickback: true, ui_508_compliant: true} ;
< 					</script>
< 				</div>
< 				<!-- ## END page-options ## -->
< <!--==== BEGIN Breadcrumbs ==== -->
< 	<div id="fda-breadcrumbs">
---
> 						<script type="text/javascript">
> 						var addthis_config = {data_track_clickback: true, ui_508_compliant: true} ;
> 						</script>
> 					</div>
> 					<!-- ## END page-options ## -->
> 	<!--==== BEGIN Breadcrumbs ==== -->
> 		<div id="fda-breadcrumbs" class="fda-breadcrumbs">
323,328c312,319
< 	<ul class="list-horizontal">
< 			<li><a href = "/default.htm" >Home</a></li>
< 			<li><a href = "/Drugs/default.htm" >Drugs</a></li>
< 			<li><a href = "/Drugs/ScienceResearch/default.htm" >Science & Research (Drugs)</a></li>
< 			<li><a href = "/Drugs/ScienceResearch/ResearchAreas/default.htm" >Additional Research Areas</a></li>
< 	</ul>
---
> 
> 		<ul class="list-horizontal contentpage">
> 									<li><a href = "/default.htm" >Home</a></li>
> 									<li><a href = "/Drugs/default.htm" >Drugs</a></li>
> 									<li><a href = "/Drugs/ScienceResearch/default.htm" >Science & Research (Drugs)</a></li>
> 				 <!-- check if second last item in NodeList -->
> 					<li class="secondLast"><a href = "/Drugs/ScienceResearch/ResearchAreas/default.htm" name = "main">Additional Research Areas</a></li>				
> 					</ul>
332a324,327
> 	<!--==== END Breadcrumbs ==== --> 
> <!--==== BEGIN Topic Page Title ==== -->
> 		<!--==== END Topic Page Title ==== --><!--==== BEGIN Breadcrumbs ==== -->
> 		<!--==== END Breadcrumbs ==== --><!--==== BEGIN LEFT-COLUMN PAGE CONTENT ==== -->
334,340c329,330
< <!--==== END Breadcrumbs ==== --> 
<  
< 
< <!--==== BEGIN Topic Page Title ==== --><!--==== END Topic Page Title ==== --><!--==== BEGIN Breadcrumbs ==== --><!--==== END Breadcrumbs ==== --><!--==== BEGIN LEFT-COLUMN PAGE CONTENT ==== -->
< 
< 	<div class="left-column">
<       <!--BEGIN Side Menu --><!--BEGIN Side Menu -->	<!-- Wrapping Style Div -->
---
> 		<div class="left-column">
> 		  <!--BEGIN Side Menu --><!--BEGIN Side Menu -->		<!-- Wrapping Style Div -->
371c361
< 					<li id="UCM259430" onclick="javascript:location.href=this.getElementsByTagName('a')[0].href" ><a href="/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm259430.htm">Overview of the Genomics Group </a></li>
---
> 					<li id="UCM259430" onclick="javascript:location.href=this.getElementsByTagName('a')[0].href" ><a href="/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm259430.htm">Overview of the Genomics and Targeted Therapy Group </a></li>
401,412c391,402
<       <div class="clearfloat">
<         -
<       </div>
<      </div>  
<     <!--==== END LEFT-COLUMN PAGE CONTENT ==== --><!--==== BEGIN MIDDLE-COLUMN PAGE CONTENT ==== -->
< <!--PAGEWATCH CODE=""-->
<     <div class="middle-column">
<       <a id="main" name="main"></a>
<       
<        <!--==== BEGIN Recalls, Market Withdrawals, & Safety Alerts Secondary Pages ==== -->
<       <h1 class="head1_body">Table of Pharmacogenomic Biomarkers in Drug Labels</h1>
<       <p>Pharmacogenomics can play an important role in identifying responders and non-responders to medications, avoiding adverse events, and optimizing drug dose. Drug labels may contain information on genomic biomarkers and can describe:</p><ul><ul><li>Drug exposure and clinical response variability</li><li>Risk for adverse events</li><li>Genotype-specific dosing</li><li>Mechanisms of drug action</li><li>Polymorphic drug target and disposition genes</li></ul></ul><p>The table below lists FDA-approved drugs with pharmacogenomic information in their labels.&nbsp;Some, but not all, of the labels include specific actions to be taken based on genetic information. Relevant sections of the label with such information are noted in the last column of the table.&nbsp;Biomarkers may include gene variants, functional deficiencies, expression changes, chromosomal abnormalities, and others. Microbial variants that influence sensitivity to anti-infectives are not included in the table. Please note that the table columns can be sorted.</p><p>Pharmacogenomic information can appear in different sections of the label. For more information on the relevance of information in various parts of the drug label (e.g. Indications and Usage, Dosage and Administration, Boxed Warning, etc.), please go to the relevant <a target="" href="/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm065010.htm">labeling guidance</a>. For information on the FDA's initiative to improve prescription drug labels, visit the <a target="" href="/Training/ForHealthProfessionals/ucm090801.htm">FDA/CDER Learn website</a>.</p> 
---
> 		  <div class="clearfloat">
> 			-
> 		  </div>
> 		</div>  
> 		<!--==== END LEFT-COLUMN PAGE CONTENT ==== --><!--==== BEGIN MIDDLE-COLUMN PAGE CONTENT ==== -->
> 		<!--PAGEWATCH CODE=""-->
> 		<div class="middle-column">
> 			<a id="main" name="main"></a>
> 		  
> 		    <!--==== BEGIN Recalls, Market Withdrawals, & Safety Alerts Secondary Pages ==== -->
> 				<h1 class="head1_body">Table of Pharmacogenomic Biomarkers in Drug Labeling</h1>
> 			  <p>Pharmacogenomics can play an important role in identifying responders and non-responders to medications, avoiding adverse events, and optimizing drug dose. Drug labeling may contain information on genomic biomarkers and can describe:</p><ul><ul><li>Drug exposure and clinical response variability</li><li>Risk for adverse events</li><li>Genotype-specific dosing</li><li>Mechanisms of drug action</li><li>Polymorphic drug target and disposition genes</li></ul></ul><p>The table below lists FDA-approved drugs with pharmacogenomic information in their labeling. The labeling for some, but not all, of the products includes specific actions to be taken based on the biomarker information. Biomarkers in the table include are not limited to germline or somatic gene variants, functional deficiencies, expression changes, and chromosomal abnormalities.</p><p>This table does not include non-human genetic biomarkers (e.g., viral or bacterial) i.e., microbial variants that influence sensitivity to anti-invectives; biomarkers that are used solely for diagnostic purposes unless they are linked to drug activity or used to identify a specific subset in whom prescribing information differs (e.g., for genetic diseases). Therapeutic areas do not necessarily reflect the FDA review division.</p><p>Pharmacogenomic information can appear in different sections of the labeling. Relevant sections of the labeling with such information are noted in the last column of the table. For more information on the relevance of information in various parts of drug labeling (e.g. Indications and Usage, Dosage and Administration, Boxed Warning, etc.), please refer to the appropriate&nbsp;<a target="" href="/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm065010.htm">labeling guidance</a>. For information on the FDA's initiative to improve prescription drug labeling, visit the <a target="" href="/Training/ForHealthProfessionals/ucm090801.htm">FDA/CDER Learn website</a>.</p> 
442a433
> 					  
444c435,436
< 					  			     
---
> 							
> 					  				     
452c444
< 				<div class='box'><div class='box_top'><div>-</div></div><div class='box_body'><div><h2 class='head3'>Pharmacogenomic Biomarkers in Drug Labels</h2><p>           </p><ul><table width='100%' class='tablesorter' cellspacing='2' id='customTable'> <thead> <tr><th id='' name='' title='Click to Sort By Drug' scope='col'>Drug</th><th id='' name='' title='Click to Sort By Therapeutic Area' scope='col'>Therapeutic Area</th><th id='' name='' title='Click to Sort By Biomarker' scope='col'>Biomarker</th><th id='' name='' title='Click to Sort By Label Sections' scope='col'>Label Sections</th></tr> </thead> <tbody>
---
> 				<div class='box'><div class='box_top'><div>-</div></div><div class='box_body'><div><h2 class='head3'>Pharmacogenomic Biomarkers in Drug Labeling</h2><p>           </p><ul><table width='100%' class='table table-striped tablesorter' cellspacing='2' id='customTable'> <thead> <tr><th id='' name='' title='Click to Sort By Drug' scope='col'>Drug</th><th id='' name='' title='Click to Sort By Therapeutic Area' scope='col'>Therapeutic Area</th><th id='' name='' title='Click to Sort By HUGO Symbol' scope='col'>HUGO Symbol</th><th id='' name='' title='Click to Sort By Referenced Subgroup' scope='col'>Referenced Subgroup</th><th id='' name='' title='Click to Sort By Labeling Sections' scope='col'>Labeling Sections</th></tr> </thead> <tbody>
467c459,462
< 								Antivirals 
---
> 								Infectious Diseases 
> 						</td>
> 						<td>
> 								HLA-B 
470c465
< 								HLA-B*5701 
---
> 								HLA-B*5701 allele carriers 
504c499,503
< 								ERBB2 (HER2) 
---
> 								ERBB2 
> 						</td>
> 						<td>
> 								HER2 protein overexpression or 
> gene amplification positive 
531c530
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236063.htm target='_self'><linktitle>Aripiprazole</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372082.htm target='_self'><linktitle>Afatinib</linktitle></a> 
535c534
< 								Psychiatry 
---
> 								Oncology 
538c537
< 								CYP2D6 
---
> 								EGFR 
541c540,543
< 								Clinical Pharmacology, Dosage and Administration 
---
> 								EGFR exon 19 deletion or exon 21 substitution (L858R) mutation positive 
> 						</td>
> 						<td>
> 								Indications and Usage,  Dosage and Administration, Adverse Reactions,  Clinical Pharmacology, Clinical Studies,  Patient Counseling Information 
565c567
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236079.htm target='_self'><linktitle>Arsenic Trioxide</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372273.htm target='_self'><linktitle>Amitriptyline</linktitle></a> 
569c571
< 								Oncology 
---
> 								Psychiatry 
572c574
< 								PML/RARα 
---
> 								CYP2D6 
575c577,580
< 								Boxed Warning, Clinical Pharmacology, Indications and Usage, Warnings 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Precautions 
599c604
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236090.htm target='_self'><linktitle>Atomoxetine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372115.htm target='_self'><linktitle>Anastrozole</linktitle></a> 
603c608
< 								Psychiatry 
---
> 								Oncology 
606c611
< 								CYP2D6 
---
> 								ESR1, PGR 
609c614,617
< 								Dosage and Administration, Warnings and Precautions, Drug Interactions, Clinical Pharmacology 
---
> 								Hormone receptor positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Clinical Pharmacology, Clinical Studies 
633c641
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236175.htm target='_self'><linktitle>Atorvastatin</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236063.htm target='_self'><linktitle>Aripiprazole</linktitle></a> 
637c645
< 								Metabolic and Endocrinology 
---
> 								Psychiatry 
640c648
< 								LDL receptor 
---
> 								CYP2D6 
643c651,654
< 								Indications and Usage, Dosage and Administration, Warnings and Precautions, Clinical Pharmacology, Clinical Studies 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Dosage and Administration 
667c678
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236181.htm target='_self'><linktitle>Azathioprine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236079.htm target='_self'><linktitle>Arsenic Trioxide</linktitle></a> 
671c682
< 								Rheumatology 
---
> 								Oncology 
674c685
< 								TPMT 
---
> 								PML/RARA 
677c688,691
< 								Dosage and Administration, Warnings and Precautions, Drug Interactions, Adverse Reactions, Clinical Pharmacology 
---
> 								PML/RARα (t(15;17)) gene expression positive 
> 						</td>
> 						<td>
> 								Boxed Warning, Clinical Pharmacology, Indications and Usage, Warnings 
701c715
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm256294.htm target='_self'><linktitle>Boceprevir</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236090.htm target='_self'><linktitle>Atomoxetine</linktitle></a> 
705c719
< 								Antivirals 
---
> 								Psychiatry 
708c722
< 								IL28B 
---
> 								CYP2D6 
711c725,728
< 								Clinical Pharmacology 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Dosage and Administration, Warnings and Precautions, Drug Interactions, Clinical Pharmacology 
735c752
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm269141.htm target='_self'><linktitle>Brentuximab Vedotin</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236175.htm target='_self'><linktitle>Atorvastatin</linktitle></a> 
739c756
< 								Oncology 
---
> 								Endocrinology 
742c759
< 								CD30 
---
> 								LDLR 
745c762,765
< 								Indications and Usage, Description, Clinical Pharmacology 
---
> 								Homozygous familial hypercholesterolemia 
> 						</td>
> 						<td>
> 								Indications and Usage, Dosage and Administration, Warnings and Precautions, Clinical Pharmacology, Clinical Studies 
769c789
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236246.htm target='_self'><linktitle>Busulfan</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236181.htm target='_self'><linktitle>Azathioprine</linktitle></a> 
773c793
< 								Oncology 
---
> 								Rheumatology 
776c796
< 								Ph Chromosome 
---
> 								TPMT 
779c799,802
< 								Clinical Studies 
---
> 								TPMT intermediate or poor metabolizers 
> 						</td>
> 						<td>
> 								Dosage and Administration, Warnings and Precautions, Drug Interactions, Adverse Reactions, Clinical Pharmacology 
803c826
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236253.htm target='_self'><linktitle>Capecitabine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372149.htm target='_self'><linktitle>Belimumab</linktitle></a> 
807c830,833
< 								Oncology 
---
> 								Autoimmune Diseases 
> 						</td>
> 						<td>
> 								BAFF/TNFSF13B 
810c836
< 								DPD 
---
> 								CD257 positive 
813c839
< 								Contraindications, Precautions, Patient Information 
---
> 								Clinical Pharmacology, Clinical Studies 
837c863
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236254.htm target='_self'><linktitle>Carbamazepine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm256294.htm target='_self'><linktitle>Boceprevir</linktitle></a> 
841c867
< 								Neurology 
---
> 								Infectious Diseases 
844c870
< 								HLA-B*1502 
---
> 								IFNL3 
847c873,876
< 								Boxed Warning, Warnings and Precautions 
---
> 								IL28B rs12979860 T allele carriers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology 
871c900
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm266929.htm target='_self'><linktitle>Carisoprodol</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372155.htm target='_self'><linktitle>Bosutinib</linktitle></a> 
875c904,907
< 								Musculoskeletal 
---
> 								Oncology 
> 						</td>
> 						<td>
> 								BCR/ABL1 
878c910
< 								CYP2C19 
---
> 								Philadelphia chromosome (t(9;22)) positive 
881c913
< 								Clinical Pharmacology, Special Populations 
---
> 								Indications and Usage, Adverse Reactions, Clinical Studies 
905c937
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236255.htm target='_self'><linktitle>Carvedilol</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm269141.htm target='_self'><linktitle>Brentuximab Vedotin</linktitle></a> 
909c941
< 								Cardiovascular 
---
> 								Oncology 
912c944
< 								CYP2D6 
---
> 								TNFRSF8 
915c947,950
< 								Drug Interactions, Clinical Pharmacology 
---
> 								CD30 positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Description, Clinical Pharmacology 
939c974
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236256.htm target='_self'><linktitle>Celecoxib</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236246.htm target='_self'><linktitle>Busulfan</linktitle></a> 
943c978
< 								Analgesics 
---
> 								Oncology 
946c981
< 								CYP2C9 
---
> 								Ph Chromosome 
949c984,987
< 								Dosage and Administration, Drug Interactions, Use in Specific Populations, Clinical Pharmacology 
---
> 								Ph Chromosome negative 
> 						</td>
> 						<td>
> 								Clinical Studies 
973c1011
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236268.htm target='_self'><linktitle>Cetuximab (1)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236253.htm target='_self'><linktitle>Capecitabine</linktitle></a> 
980c1018
< 								EGFR 
---
> 								DPYD 
983c1021,1024
< 								Indications and Usage, Warnings and Precautions, Description, Clinical Pharmacology, Clinical Studies 
---
> 								DPD deficient 
> 						</td>
> 						<td>
> 								Contraindications, Warnings and Precautions, Patient Information 
1007c1048
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236274.htm target='_self'><linktitle>Cetuximab (2)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236254.htm target='_self'><linktitle>Carbamazepine (1)</linktitle></a> 
1011c1052
< 								Oncology 
---
> 								Neurology 
1014c1055
< 								KRAS 
---
> 								HLA-B 
1017c1058,1061
< 								Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology, Clinical Studies 
---
> 								HLA-B*1502 allele carriers 
> 						</td>
> 						<td>
> 								Boxed Warning, Warnings and Precautions 
1041c1085
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236276.htm target='_self'><linktitle>Cevimeline</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372156.htm target='_self'><linktitle>Carbamazepine (2)</linktitle></a> 
1045c1089
< 								Dermatology and Dental 
---
> 								Neurology 
1048c1092
< 								CYP2D6 
---
> 								HLA-A 
1051c1095,1098
< 								Drug Interactions 
---
> 								HLA-A*3101 allele carriers 
> 						</td>
> 						<td>
> 								Boxed Warning, Warnings and Precautions 
1075c1122
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267450.htm target='_self'><linktitle>Chlordiazepoxide and Amitriptyline</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372160.htm target='_self'><linktitle>Carglumic Acid</linktitle></a> 
1079c1126
< 								Psychiatry 
---
> 								Metabolic Disorders 
1082c1129
< 								CYP2D6 
---
> 								NAGS 
1085c1132,1135
< 								Precautions 
---
> 								N-acetylglutamate synthase deficiency 
> 						</td>
> 						<td>
> 								Indications and Usage,  Warnings and Precautions,  Special Populations,  Clinical Pharmacology, Clinical Studies 
1109c1159
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236277.htm target='_self'><linktitle>Chloroquine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm266929.htm target='_self'><linktitle>Carisoprodol</linktitle></a> 
1113c1163
< 								Antiinfectives 
---
> 								Rheumatology 
1116c1166
< 								G6PD 
---
> 								CYP2C19 
1119c1169,1172
< 								Precautions 
---
> 								CYP2C19 poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Special Populations 
1143c1196
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm287714.htm target='_self'><linktitle>Cisplatin</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236255.htm target='_self'><linktitle>Carvedilol</linktitle></a> 
1147c1200
< 								Oncology 
---
> 								Cardiology 
1150c1203
< 								TPMT 
---
> 								CYP2D6 
1153c1206,1209
< 								Clinical Pharmacology, Warnings, Precautions 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Drug Interactions, Clinical Pharmacology 
1177c1233
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267567.htm target='_self'><linktitle>Citalopram (1)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236256.htm target='_self'><linktitle>Celecoxib</linktitle></a> 
1181c1237
< 								Psychiatry 
---
> 								Rheumatology 
1184c1240
< 								CYP2C19 
---
> 								CYP2C9 
1187c1243,1246
< 								Drug Interactions, Warnings 
---
> 								CYP2C9 poor metabolizers 
> 						</td>
> 						<td>
> 								Dosage and Administration, Drug Interactions, Use in Specific Populations, Clinical Pharmacology 
1211c1270
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267568.htm target='_self'><linktitle>Citalopram (2)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236268.htm target='_self'><linktitle>Cetuximab (1)</linktitle></a> 
1215c1274
< 								Psychiatry 
---
> 								Oncology 
1218c1277
< 								CYP2D6 
---
> 								EGFR 
1221c1280,1283
< 								Drug Interactions 
---
> 								EGFR protein expression positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Warnings and Precautions, Description, Clinical Pharmacology, Clinical Studies 
1245c1307
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm278224.htm target='_self'><linktitle>Clobazam</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236274.htm target='_self'><linktitle>Cetuximab (2)</linktitle></a> 
1249c1311
< 								Neurology 
---
> 								Oncology 
1252c1314
< 								CYP2C19 
---
> 								KRAS 
1255c1317,1320
< 								Clinical Pharmacology, Dosage and Administration, Use in Specific Populations 
---
> 								KRAS codon 12 and 13 mutation negative 
> 						</td>
> 						<td>
> 								Indications and Usage, Dosage and Administration, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology, Clinical Studies 
1279c1344
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267576.htm target='_self'><linktitle>Clomipramine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236276.htm target='_self'><linktitle>Cevimeline</linktitle></a> 
1283c1348
< 								Psychiatry 
---
> 								Dermatology 
1288a1354,1356
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
1313c1381
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236280.htm target='_self'><linktitle>Clopidogrel</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236277.htm target='_self'><linktitle>Chloroquine</linktitle></a> 
1317c1385
< 								Cardiovascular 
---
> 								Infectious Diseases 
1320c1388
< 								CYP2C19 
---
> 								G6PD 
1323c1391,1394
< 								Boxed Warning, Dosage and Administration, Warnings and Precautions, Drug Interactions, Clinical Pharmacology 
---
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Precautions 
1347c1418
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236282.htm target='_self'><linktitle>Clozapine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372311.htm target='_self'><linktitle>Chlorpropamide</linktitle></a> 
1351c1422
< 								Psychiatry 
---
> 								Endocrinology 
1354c1425
< 								CYP2D6 
---
> 								G6PD 
1357c1428,1431
< 								Drug Interactions, Clinical Pharmacology 
---
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Precautions 
1381c1455
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236284.htm target='_self'><linktitle>Codeine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm287714.htm target='_self'><linktitle>Cisplatin</linktitle></a> 
1385c1459
< 								Analgesics 
---
> 								Oncology 
1388c1462
< 								CYP2D6 
---
> 								TPMT 
1391c1465,1468
< 								Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology 
---
> 								TPMT intermediate or poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Warnings, Precautions 
1415c1492
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm273399.htm target='_self'><linktitle>Crizotinib</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267567.htm target='_self'><linktitle>Citalopram (1)</linktitle></a> 
1419c1496
< 								Oncology 
---
> 								Psychiatry 
1422c1499
< 								ALK 
---
> 								CYP2C19 
1425c1502,1506
< 								Indications and Usage, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology, Clinical Studies 
---
> 								CYP2C19
> poor metabolizers 
> 						</td>
> 						<td>
> 								Drug Interactions, Warnings 
1449c1530
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236290.htm target='_self'><linktitle>Dapsone (1)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267568.htm target='_self'><linktitle>Citalopram (2)</linktitle></a> 
1453c1534
< 								Dermatology 
---
> 								Psychiatry 
1456c1537,1540
< 								G6PD 
---
> 								CYP2D6 
> 						</td>
> 						<td>
> 								CYP2D6 poor metabolizers 
1459c1543
< 								Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Patient Counseling Information 
---
> 								Drug Interactions 
1483c1567
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm357545.htm target='_self'><linktitle>Dapsone (2)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm278224.htm target='_self'><linktitle>Clobazam</linktitle></a> 
1487c1571
< 								Antiinfectives 
---
> 								Neurology 
1490c1574
< 								G6PD 
---
> 								CYP2C19 
1493c1577,1580
< 								Precautions, Adverse Reactions, Overdosage 
---
> 								CYP2C19 poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Dosage and Administration, Use in Specific Populations 
1517c1604
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236294.htm target='_self'><linktitle>Dasatinib</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267576.htm target='_self'><linktitle>Clomipramine</linktitle></a> 
1521c1608
< 								Oncology 
---
> 								Psychiatry 
1524c1611
< 								Ph Chromosome 
---
> 								CYP2D6 
1527c1614,1617
< 								Indications and Usage, Clinical Studies, Patient Counseling Information 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Drug Interactions 
1551c1641
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm301999.htm target='_self'><linktitle>Denileukin Diftitox</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236280.htm target='_self'><linktitle>Clopidogrel</linktitle></a> 
1555c1645,1648
< 								Oncology 
---
> 								Cardiology 
> 						</td>
> 						<td>
> 								CYP2C19 
1558c1651
< 								CD25 
---
> 								CYP2C19 intermediate or poor metabolizers 
1561c1654
< 								Indications and Usage, Warnings and Precautions, Clinical Studies 
---
> 								Boxed Warning, Dosage and Administration, Warnings and Precautions, Drug Interactions, Clinical Pharmacology 
1585c1678
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267045.htm target='_self'><linktitle>Desipramine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236282.htm target='_self'><linktitle>Clozapine</linktitle></a> 
1595c1688,1691
< 								Drug Interactions 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Drug Interactions, Clinical Pharmacology 
1619c1715
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm262875.htm target='_self'><linktitle>Dexlansoprazole (1)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236284.htm target='_self'><linktitle>Codeine</linktitle></a> 
1623c1719
< 								Gastroenterology 
---
> 								Anesthesiology 
1626c1722
< 								CYP2C19 
---
> 								CYP2D6 
1629c1725,1728
< 								Clinical Pharmacology, Drug Interactions 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Warnings and Precautions, Use in Specific Populations, Clinical Pharmacology 
1653c1752
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267055.htm target='_self'><linktitle>Dexlansoprazole (2)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm273399.htm target='_self'><linktitle>Crizotinib</linktitle></a> 
1657c1756
< 								Gastroenterology 
---
> 								Oncology 
1660c1759
< 								CYP1A2 
---
> 								ALK 
1663c1762,1765
< 								Clinical Pharmacology 
---
> 								ALK gene rearrangement positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Dosage and Administration, Drug Interactions, Warnings and Precautions, Adverse Reactions, Clinical Pharmacology, Clinical Studies 
1687c1789
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm238561.htm target='_self'><linktitle>Dextromethorphan and Quinidine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372367.htm target='_self'><linktitle>Dabrafenib (1)</linktitle></a> 
1691c1793
< 								Neurology 
---
> 								Oncology 
1694c1796
< 								CYP2D6 
---
> 								BRAF 
1697c1799,1802
< 								Clinical Pharmacology, Warnings and Precautions 
---
> 								BRAF V600E mutation positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Dosage and Administration, Warnings and Precautions, Clinical Pharmacology, Clinical Studies, Patient Counseling Information 
1721c1826
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236311.htm target='_self'><linktitle>Diazepam</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372369.htm target='_self'><linktitle>Dabrafenib (2)</linktitle></a> 
1725c1830
< 								Psychiatry 
---
> 								Oncology 
1728c1833
< 								CYP2C19 
---
> 								G6PD 
1731c1836,1839
< 								Drug Interactions, Clinical Pharmacology 
---
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Warnings and Precautions, Adverse Reactions, Patient Counseling Information 
1755c1863
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236325.htm target='_self'><linktitle>Doxepin</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236290.htm target='_self'><linktitle>Dapsone (1)</linktitle></a> 
1759c1867
< 								Psychiatry 
---
> 								Dermatology 
1762c1870
< 								CYP2D6 
---
> 								G6PD 
1765c1873,1876
< 								Precautions 
---
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Indications and Usage, Precautions, Adverse Reactions, Patient Counseling Information 
1789c1900
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236328.htm target='_self'><linktitle>Drospirenone and Ethinyl Estradiol</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm357545.htm target='_self'><linktitle>Dapsone (2)</linktitle></a> 
1793c1904
< 								Reproductive 
---
> 								Infectious Diseases 
1796c1907,1910
< 								CYP2C19 
---
> 								G6PD 
> 						</td>
> 						<td>
> 								G6PD deficient 
1799c1913
< 								Precautions, Drug Interactions 
---
> 								Precautions, Adverse Reactions, Overdosage 
1823c1937
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm320300.htm target='_self'><linktitle>Eltrombopag (1)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236294.htm target='_self'><linktitle>Dasatinib</linktitle></a> 
1827c1941
< 								Hematology 
---
> 								Oncology 
1830c1944
< 								Factor V Leiden (FV) 
---
> 								BCR/ABL1 
1833c1947,1950
< 								Warnings and Precautions 
---
> 								Philadelphia chromosome (t(9;22)) positive; T315I mutation-positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Clinical Studies, Patient Counseling Information 
1857c1974
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm320303.htm target='_self'><linktitle>Eltrombopag (2)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm301999.htm target='_self'><linktitle>Denileukin Diftitox</linktitle></a> 
1861c1978
< 								Hematology 
---
> 								Oncology 
1864c1981
< 								Antithrombin III deficiency (SERPINC1) 
---
> 								IL2RA 
1867c1984,1987
< 								Warnings and Precautions 
---
> 								CD25 antigen positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Warnings and Precautions, Clinical Studies 
1891c2011
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236331.htm target='_self'><linktitle>Erlotinib</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267045.htm target='_self'><linktitle>Desipramine</linktitle></a> 
1895c2015
< 								Oncology 
---
> 								Psychiatry 
1898c2018
< 								EGFR 
---
> 								CYP2D6 
1901c2021,2024
< 								Clinical Pharmacology 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Drug Interactions 
1925c2048
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236406.htm target='_self'><linktitle>Esomeprazole</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm262875.htm target='_self'><linktitle>Dexlansoprazole (1)</linktitle></a> 
1935c2058,2061
< 								Drug Interactions, Clinical Pharmacology 
---
> 								CYP2C19 poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Drug Interactions 
1959c2085
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm314351.htm target='_self'><linktitle>Everolimus</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267055.htm target='_self'><linktitle>Dexlansoprazole (2)</linktitle></a> 
1963c2089
< 								Oncology 
---
> 								Gastroenterology 
1966c2092
< 								ERBB2 (HER2) 
---
> 								CYP1A2 
1969c2095,2098
< 								Indications and Usage, Boxed Warning, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies 
---
> 								CYP1A2 genotypes 
> 						</td>
> 						<td>
> 								Clinical Pharmacology 
1993c2122
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm293048.htm target='_self'><linktitle>Exemestane</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm238561.htm target='_self'><linktitle>Dextromethorphan and Quinidine</linktitle></a> 
1997c2126,2129
< 								Oncology 
---
> 								Neurology 
> 						</td>
> 						<td>
> 								CYP2D6 
2000c2132
< 								ER &/ PGR 
---
> 								CYP2D6 poor metabolizers 
2003c2135
< 								Indications and Usage, Dosage and Administration, Clinical Studies, Clinical Pharmacology 
---
> 								Clinical Pharmacology, Warnings and Precautions, Drug Interactions 
2027c2159
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236410.htm target='_self'><linktitle>Fluorouracil (1)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236311.htm target='_self'><linktitle>Diazepam</linktitle></a> 
2031c2163,2166
< 								Dermatology 
---
> 								Psychiatry 
> 						</td>
> 						<td>
> 								CYP2C19 
2034c2169
< 								DPD 
---
> 								CYP2C19 poor metabolizers 
2037c2172
< 								Contraindications, Warnings 
---
> 								Drug Interactions, Clinical Pharmacology 
2061c2196
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm357551.htm target='_self'><linktitle>Fluorouracil (2)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236325.htm target='_self'><linktitle>Doxepin</linktitle></a> 
2065c2200,2203
< 								Oncology 
---
> 								Psychiatry 
> 						</td>
> 						<td>
> 								CYP2D6 
2068c2206
< 								DPD 
---
> 								CYP2D6 poor metabolizers 
2071c2209
< 								Warnings 
---
> 								Precautions 
2095c2233
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236420.htm target='_self'><linktitle>Fluoxetine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236328.htm target='_self'><linktitle>Drospirenone and Ethinyl Estradiol</linktitle></a> 
2099c2237
< 								Psychiatry 
---
> 								Neurology 
2105c2243,2246
< 								Warnings, Precautions, Clinical Pharmacology 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Warnings and Precautions, Drug Interactions 
2129c2270
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236521.htm target='_self'><linktitle>Fluoxetine and Olanzapine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm320300.htm target='_self'><linktitle>Eltrombopag (1)</linktitle></a> 
2133c2274
< 								Psychiatry 
---
> 								Hematology 
2136c2277
< 								CYP2D6 
---
> 								F5 
2139c2280,2283
< 								Drug Interactions, Clinical Pharmacology 
---
> 								Factor V Leiden carriers 
> 						</td>
> 						<td>
> 								Warnings and Precautions 
2163c2307
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm265687.htm target='_self'><linktitle>Flurbiprofen</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm320303.htm target='_self'><linktitle>Eltrombopag (2)</linktitle></a> 
2167c2311
< 								Rheumatology 
---
> 								Hematology 
2170c2314
< 								CYP2C9 
---
> 								SERPINC1 
2173c2317,2320
< 								Clinical Pharmacology, Special Populations 
---
> 								Antithrombin III deficient 
> 						</td>
> 						<td>
> 								Warnings and Precautions 
2197c2344
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267074.htm target='_self'><linktitle>Fluvoxamine </linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236331.htm target='_self'><linktitle>Erlotinib (1)</linktitle></a> 
2201c2348
< 								Psychiatry 
---
> 								Oncology 
2204c2351
< 								CYP2D6 
---
> 								EGFR 
2207c2354,2357
< 								Drug Interactions 
---
> 								EGFR protein expression positive 
> 						</td>
> 						<td>
> 								Clinical Pharmacology 
2231c2381
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm249748.htm target='_self'><linktitle>Fulvestrant</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372372.htm target='_self'><linktitle>Erlotinib (2)</linktitle></a> 
2238c2388
< 								ER 
---
> 								EGFR 
2241c2391,2394
< 								Indications and Usage, Patient Counseling Information 
---
> 								EGFR exon 19 deletion or exon 21 substitution (L858R) positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies 
2265c2418
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267175.htm target='_self'><linktitle>Galantamine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236406.htm target='_self'><linktitle>Esomeprazole</linktitle></a> 
2269c2422
< 								Neurology 
---
> 								Gastroenterology 
2272c2425
< 								CYP2D6 
---
> 								CYP2C19 
2275c2428,2431
< 								Special Populations 
---
> 								CYP2C19 poor metabolizers 
> 						</td>
> 						<td>
> 								Drug Interactions, Clinical Pharmacology 
2299c2455
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236530.htm target='_self'><linktitle>Gefitinib </linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm314351.htm target='_self'><linktitle>Everolimus (1)</linktitle></a> 
2306c2462
< 								EGFR 
---
> 								ERBB2 
2309c2465,2468
< 								Clinical Pharmacology 
---
> 								HER2 protein overexpression negative 
> 						</td>
> 						<td>
> 								Indications and Usage, Boxed Warning, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies 
2333c2492
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267303.htm target='_self'><linktitle>Iloperidone</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372375.htm target='_self'><linktitle>Everolimus (2)</linktitle></a> 
2337c2496
< 								Psychiatry 
---
> 								Oncology 
2340c2499
< 								CYP2D6 
---
> 								ESR1 
2343c2502,2505
< 								Clinical Pharmacology, Dosage and Administration, Drug Interactions, Specific Populations, Warnings and Precautions 
---
> 								Estrogen receptor positive 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Clinical Studies 
2367c2529
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236532.htm target='_self'><linktitle>Imatinib (1)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm293048.htm target='_self'><linktitle>Exemestane</linktitle></a> 
2374c2536
< 								C-Kit 
---
> 								ESR1 
2377c2539,2542
< 								Indications and Usage, Dosage and Administration Clinical Pharmacology, Clinical Studies 
---
> 								Estrogen receptor positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Dosage and Administration, Clinical Studies, Clinical Pharmacology 
2401c2566
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236533.htm target='_self'><linktitle>Imatinib (2)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236410.htm target='_self'><linktitle>Fluorouracil (1)</linktitle></a> 
2405c2570
< 								Oncology 
---
> 								Dermatology 
2408c2573
< 								Ph Chromosome 
---
> 								DPYD 
2411c2576,2579
< 								Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies 
---
> 								DPD deficient 
> 						</td>
> 						<td>
> 								Contraindications, Warnings, Patient Information 
2435c2603
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm249743.htm target='_self'><linktitle>Imatinib (3)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm357551.htm target='_self'><linktitle>Fluorouracil (2)</linktitle></a> 
2442c2610
< 								PDGFR 
---
> 								DPYD 
2445c2613,2616
< 								Indications and Usage, Dosage and Administration, Clincal Studies 
---
> 								DPD deficient 
> 						</td>
> 						<td>
> 								Warnings 
2469c2640
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm249744.htm target='_self'><linktitle>Imatinib (4)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236420.htm target='_self'><linktitle>Fluoxetine</linktitle></a> 
2473c2644,3862
< 								Oncology 
---
> 								Psychiatry 
> 						</td>
> 						<td>
> 								CYP2D6 
> 						</td>
> 						<td>
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Warnings, Precautions, Clinical Pharmacology 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm265687.htm target='_self'><linktitle>Flurbiprofen</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Rheumatology 
> 						</td>
> 						<td>
> 								CYP2C9 
> 						</td>
> 						<td>
> 								CYP2C9 poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Special Populations 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267074.htm target='_self'><linktitle>Fluvoxamine </linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Psychiatry 
> 						</td>
> 						<td>
> 								CYP2D6 
> 						</td>
> 						<td>
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Drug Interactions 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm249748.htm target='_self'><linktitle>Fulvestrant</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Oncology 
> 						</td>
> 						<td>
> 								ESR1 
> 						</td>
> 						<td>
> 								Estrogen receptor positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Clinical Pharmacology, Clinical Studies, Patient Counseling Information 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267175.htm target='_self'><linktitle>Galantamine</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Neurology 
> 						</td>
> 						<td>
> 								CYP2D6 
> 						</td>
> 						<td>
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Special Populations 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372503.htm target='_self'><linktitle>Glimepiride</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Endocrinology 
> 						</td>
> 						<td>
> 								G6PD 
> 						</td>
> 						<td>
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Warning and Precautions 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372506.htm target='_self'><linktitle>Glipizide</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Endocrinology 
> 						</td>
> 						<td>
> 								G6PD 
> 						</td>
> 						<td>
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Precautions 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372508.htm target='_self'><linktitle>Glyburide</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Endocrinology 
> 						</td>
> 						<td>
> 								G6PD 
> 						</td>
> 						<td>
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Precautions 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372512.htm target='_self'><linktitle>Ibritumomab Tiuxetan</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Oncology 
> 						</td>
> 						<td>
> 								MS4A1 
> 						</td>
> 						<td>
> 								CD20 positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Clinical Pharmacology, Description 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267303.htm target='_self'><linktitle>Iloperidone</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Psychiatry 
> 						</td>
> 						<td>
> 								CYP2D6 
> 						</td>
> 						<td>
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Dosage and Administration, Drug Interactions, Specific Populations, Warnings and Precautions 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236532.htm target='_self'><linktitle>Imatinib (1)</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Oncology 
> 						</td>
> 						<td>
> 								KIT 
> 						</td>
> 						<td>
> 								c-KIT D816V mutation negative 
> 						</td>
> 						<td>
> 								Indications and Usage, Dosage and Administration Clinical Pharmacology, Clinical Studies 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236533.htm target='_self'><linktitle>Imatinib (2)</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Oncology 
> 						</td>
> 						<td>
> 								BCR/ABL1 
> 						</td>
> 						<td>
> 								Philadelphia chromosome (t(9;22)) positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm249743.htm target='_self'><linktitle>Imatinib (3)</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Oncology 
> 						</td>
> 						<td>
> 								PDGFRB 
> 						</td>
> 						<td>
> 								PDGFR gene rearrangement positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Dosage and Administration, Clincal Studies 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm249744.htm target='_self'><linktitle>Imatinib (4)</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Oncology 
> 						</td>
> 						<td>
> 								FIP1L1/PDGFRA 
> 						</td>
> 						<td>
> 								FIP1L1/PDGFRα fusion kinase (or CHIC2 deletion) positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Dosage and Administration, Clinical Studies 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267581.htm target='_self'><linktitle>Imipramine</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Psychiatry 
> 						</td>
> 						<td>
> 								CYP2D6 
> 						</td>
> 						<td>
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Drug Interactions 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm283068.htm target='_self'><linktitle>Indacaterol</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Pulmonary 
> 						</td>
> 						<td>
> 								UGT1A1 
> 						</td>
> 						<td>
> 								UGT1A1 *28 allele homozygotes 
> 						</td>
> 						<td>
> 								Clinical Pharmacology 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236793.htm target='_self'><linktitle>Irinotecan</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Oncology 
> 						</td>
> 						<td>
> 								UGT1A1 
> 						</td>
> 						<td>
> 								UGT1A1*28 allele carriers 
> 						</td>
> 						<td>
> 								Dosage and Administration, Warnings, Clinical Pharmacology 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236797.htm target='_self'><linktitle>Isosorbide and Hydralazine</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Cardiology 
> 						</td>
> 						<td>
> 								NAT1-2 
> 						</td>
> 						<td>
> 								Slow acetylators 
> 						</td>
> 						<td>
> 								Clinical Pharmacology 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm290088.htm target='_self'><linktitle>Ivacaftor</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Pulmonary 
> 						</td>
> 						<td>
> 								CFTR 
> 						</td>
> 						<td>
> 								CFTR G551D, G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N, or S549R carriers 
> 						</td>
> 						<td>
> 								Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm338077.htm target='_self'><linktitle>Lansoprazole</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Gastroenterology 
> 						</td>
> 						<td>
> 								CYP2C19 
> 						</td>
> 						<td>
> 								CYP2C19 poor metabolizer 
> 						</td>
> 						<td>
> 								Drug Interactions, Clinical Pharmacology 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236799.htm target='_self'><linktitle>Lapatinib</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Oncology 
> 						</td>
> 						<td>
> 								ERBB2 
> 						</td>
> 						<td>
> 								HER2 protein overexpression positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Clinical Pharmacology, Patient Counseling Information 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236800.htm target='_self'><linktitle>Lenalidomide</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Hematology 
> 						</td>
> 						<td>
> 								del (5q) 
> 						</td>
> 						<td>
> 								Chromosome 5q deletion 
> 						</td>
> 						<td>
> 								Boxed Warning, Indications and Usage, Clinical Studies, Patient Counseling 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm293044.htm target='_self'><linktitle>Letrozole</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Oncology 
> 						</td>
> 						<td>
> 								ESR1, PGR 
> 						</td>
> 						<td>
> 								Hormone receptor positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Adverse Reactions, Clinical Studies, Clinical Pharmacology 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372516.htm target='_self'><linktitle>Lomitapide</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Endocrinology 
> 						</td>
> 						<td>
> 								LDLR 
> 						</td>
> 						<td>
> 								Homozygous familial hypercholesterolemia and LDL receptor mutation deficient 
> 						</td>
> 						<td>
> 								Indication and Usage, Adverse Reactions, Clinical Studies 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372581.htm target='_self'><linktitle>Mafenide</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Infectious Diseases 
> 						</td>
> 						<td>
> 								G6PD 
> 						</td>
> 						<td>
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Warnings, Adverse Reactions 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236802.htm target='_self'><linktitle>Maraviroc</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Infectious Diseases 
> 						</td>
> 						<td>
> 								CCR5 
> 						</td>
> 						<td>
> 								CCR5 positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Warnings and Precautions, Clinical Pharmacology, Clinical Studies, Patient Counseling Information 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236814.htm target='_self'><linktitle>Mercaptopurine</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Oncology 
> 						</td>
> 						<td>
> 								TPMT 
> 						</td>
> 						<td>
> 								TPMT intermediate or poor metabolizers 
> 						</td>
> 						<td>
> 								Dosage and Administration, Contraindications, Precautions, Adverse Reactions, Clinical Pharmacology 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372586.htm target='_self'><linktitle>Methylene Blue</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Hematology 
> 						</td>
> 						<td>
> 								G6PD 
> 						</td>
> 						<td>
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Precautions 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372588.htm target='_self'><linktitle>Metoclopramide</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Gastroentrology 
> 						</td>
> 						<td>
> 								CYB5R1-4 
> 						</td>
> 						<td>
> 								NADH cytochrome b5 reductase deficient 
> 						</td>
> 						<td>
> 								Precautions 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236819.htm target='_self'><linktitle>Metoprolol</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Cardiology 
> 						</td>
> 						<td>
> 								CYP2D6 
> 						</td>
> 						<td>
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Precautions, Clinical Pharmacology 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372598.htm target='_self'><linktitle>Mipomersen</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Endocrinology 
> 						</td>
> 						<td>
> 								LDLR 
> 						</td>
> 						<td>
> 								Homozygous familial hypercholesterolemia and LDL receptor mutation deficient 
> 						</td>
> 						<td>
> 								Indication and Usage, Clinical Studies, Use in Specific Populations 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267315.htm target='_self'><linktitle>Modafinil </linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Psychiatry 
> 						</td>
> 						<td>
> 								CYP2D6 
> 						</td>
> 						<td>
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Drug Interactions 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm321881.htm target='_self'><linktitle>Mycophenolic Acid</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Transplantation 
> 						</td>
> 						<td>
> 								HPRT1 
> 						</td>
> 						<td>
> 								HGPRT deficient 
> 						</td>
> 						<td>
> 								Precautions 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
> 
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372601.htm target='_self'><linktitle>Nalidixic Acid</linktitle></a> 
> 
2476c3865
< 								FIP1L1-PDGFRα 
---
> 								Infectious Diseases 
2479c3868,3874
< 								Indications and Usage, Dosage and Administration, Clinical Studies 
---
> 								G6PD 
> 						</td>
> 						<td>
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Precautions, Adverse Reactions 
2503c3898
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267581.htm target='_self'><linktitle>Imipramine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm268751.htm target='_self'><linktitle>Nefazodone</linktitle></a> 
2512a3908,3910
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
2537c3935
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm283068.htm target='_self'><linktitle>Indacaterol</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237444.htm target='_self'><linktitle>Nilotinib (1)</linktitle></a> 
2541c3939
< 								Pulmonary 
---
> 								Oncology 
2544c3942
< 								UGT1A1 
---
> 								BCR/ABL1 
2547c3945,3948
< 								Clinical Pharmacology 
---
> 								Philadelphia chromosome (t(9 :22)) positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Patient Counseling Information 
2571c3972
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236793.htm target='_self'><linktitle>Irinotecan</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237446.htm target='_self'><linktitle>Nilotinib (2)</linktitle></a> 
2581c3982,3985
< 								Dosage and Administration, Warnings, Clinical Pharmacology 
---
> 								UGT1A1*28 allele homozygotes 
> 						</td>
> 						<td>
> 								Warnings and Precautions, Clinical Pharmacology 
2605c4009
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236797.htm target='_self'><linktitle>Isosorbide and Hydralazine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372608.htm target='_self'><linktitle>Nitrofurantoin</linktitle></a> 
2609c4013
< 								Cardiovascular 
---
> 								Infectious Diseases 
2612c4016
< 								NAT1; NAT2 
---
> 								G6PD 
2615c4019,4022
< 								Clinical Pharmacology 
---
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Warnings, Adverse Reactions 
2639c4046
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm290088.htm target='_self'><linktitle>Ivacaftor</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267362.htm target='_self'><linktitle>Nortriptyline</linktitle></a> 
2643c4050
< 								Pulmonary 
---
> 								Psychiatry 
2646c4053
< 								CFTR (G551D) 
---
> 								CYP2D6 
2649c4056,4059
< 								Indications and Usage, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Drug Interactions 
2673c4083
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm338077.htm target='_self'><linktitle>Lansoprazole</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372611.htm target='_self'><linktitle>Ofatumumab</linktitle></a> 
2677c4087
< 								Gastroenterology 
---
> 								Oncology 
2680c4090
< 								CYP2C19 
---
> 								MS4A1 
2683c4093,4096
< 								Drug Interactions, Clinical Pharmacology 
---
> 								CD20 positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Clinical Pharmacology 
2707c4120
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236799.htm target='_self'><linktitle>Lapatinib</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372614.htm target='_self'><linktitle>Omacetaxine</linktitle></a> 
2714c4127
< 								ERBB2 (HER2) 
---
> 								BCR/ABL1 
2717c4130,4133
< 								Indications and Usage, Clinical Pharmacology, Patient Counseling Information 
---
> 								BCR-ABL T315I 
> 						</td>
> 						<td>
> 								Clinical Pharmacology 
2741c4157
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236800.htm target='_self'><linktitle>Lenalidomide</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm283066.htm target='_self'><linktitle>Omeprazole</linktitle></a> 
2745c4161,4164
< 								Hematology 
---
> 								Gastroenterology 
> 						</td>
> 						<td>
> 								CYP2C19 
2748c4167
< 								Chromosome 5q 
---
> 								CYP2C19 poor metabolizers 
2751c4170
< 								Boxed Warning, Indications and Usage, Clinical Studies, Patient Counseling 
---
> 								Dosage and Administration, Warnings and Precautions, Drug Interactions 
2775c4194
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm293044.htm target='_self'><linktitle>Letrozole</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237449.htm target='_self'><linktitle>Panitumumab (1)</linktitle></a> 
2782c4201
< 								ER &/ PGR 
---
> 								EGFR 
2785c4204,4207
< 								Indications and Usage, Adverse Reactions, Clinical Studies, Clinical Pharmacology 
---
> 								EGFR protein expression positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Warnings and Precautions, Clinical Pharmacology, Clinical Studies 
2809c4231
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236802.htm target='_self'><linktitle>Maraviroc</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237474.htm target='_self'><linktitle>Panitumumab (2)</linktitle></a> 
2813c4235
< 								Antivirals 
---
> 								Oncology 
2816c4238
< 								CCR5 
---
> 								KRAS 
2819c4241,4244
< 								Indications and Usage, Warnings and Precautions, Clinical Pharmacology, Clinical Studies, Patient Counseling Information 
---
> 								KRAS codon 12 and 13 mutation negative 
> 						</td>
> 						<td>
> 								Indications and Usage, Clinical Pharmacology, Clinical Studies 
2843c4268
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236814.htm target='_self'><linktitle>Mercaptopurine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267371.htm target='_self'><linktitle>Pantoprazole</linktitle></a> 
2847c4272
< 								Oncology 
---
> 								Gastroenterology 
2850c4275
< 								TPMT 
---
> 								CYP2C19 
2853c4278,4281
< 								Dosage and Administration, Contraindications, Precautions, Adverse Reactions, Clinical Pharmacology 
---
> 								CYP2C19 poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Drug Interactions, Special Populations 
2877c4305
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm236819.htm target='_self'><linktitle>Metoprolol</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267381.htm target='_self'><linktitle>Paroxetine</linktitle></a> 
2881c4309
< 								Cardiovascular 
---
> 								Psychiatry 
2887c4315,4318
< 								Precautions, Clinical Pharmacology 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Drug Interactions 
2911c4342
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267315.htm target='_self'><linktitle>Modafinil </linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm380036.htm target='_self'><linktitle>Pazopanib</linktitle></a> 
2915c4346
< 								Psychiatry 
---
> 								Oncology 
2918c4349
< 								CYP2D6 
---
> 								UGT1A1 
2921c4352,4355
< 								Drug Interactions 
---
> 								(TA)7/(TA)7 genotype (UGT1A1*28/*28) 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Warnings and Precautions 
2945c4379
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm321881.htm target='_self'><linktitle>Mycophenolic Acid</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372653.htm target='_self'><linktitle>PEG-3350, Sodium Sulfate, Sodium Chloride, Potassium Chloride, Sodium Ascorbate, and Ascorbic Acid</linktitle></a> 
2949c4383
< 								Transplantation 
---
> 								Gastroenterology 
2952c4386
< 								HGPRT 
---
> 								G6PD 
2955c4389,4392
< 								Precautions 
---
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Warnings and Precautions 
2979c4416
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm268751.htm target='_self'><linktitle>Nefazodone</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm256296.htm target='_self'><linktitle>Peginterferon alfa-2b</linktitle></a> 
2983c4420
< 								Psychiatry 
---
> 								Infectious Diseases 
2986c4423
< 								CYP2D6 
---
> 								IFNL3 
2989c4426,4429
< 								Drug Interactions 
---
> 								IL28B rs12979860 T allele carriers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology 
3013c4453
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237444.htm target='_self'><linktitle>Nilotinib (1)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372818.htm target='_self'><linktitle>Pegloticase</linktitle></a> 
3017c4457
< 								Oncology 
---
> 								Rheumatology 
3020c4460
< 								Ph Chromosome 
---
> 								G6PD 
3023c4463,4467
< 								Indications and Usage, Patient Counseling Information 
---
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Contraindications,
> Patient Counseling Information 
3047c4491
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237446.htm target='_self'><linktitle>Nilotinib (2)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267726.htm target='_self'><linktitle>Perphenazine</linktitle></a> 
3051c4495
< 								Oncology 
---
> 								Psychiatry 
3054c4498
< 								UGT1A1 
---
> 								CYP2D6 
3057c4501,4504
< 								Warnings and Precautions, Clinical Pharmacology 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Drug Interactions 
3081c4528
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267362.htm target='_self'><linktitle>Nortriptyline</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm309050.htm target='_self'><linktitle>Pertuzumab</linktitle></a> 
3085c4532
< 								Psychiatry 
---
> 								Oncology 
3088c4535
< 								CYP2D6 
---
> 								ERBB2 
3091c4538,4541
< 								Drug Interactions 
---
> 								HER2 protein overexpression positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Warnings and Precautions, Adverse Reactions, Clinical Studies, Clinical Pharmacology 
3115c4565
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm283066.htm target='_self'><linktitle>Omeprazole</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm280936.htm target='_self'><linktitle>Phenytoin</linktitle></a> 
3119c4569
< 								Gastroenterology 
---
> 								Neurology 
3122c4572
< 								CYP2C19 
---
> 								HLA-B 
3125c4575,4578
< 								Dosage and Administration, Warnings and Precautions, Drug Interactions 
---
> 								HLA-B*1502 allele carriers 
> 						</td>
> 						<td>
> 								Warnings 
3149c4602
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237449.htm target='_self'><linktitle>Panitumumab (1)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm274355.htm target='_self'><linktitle>Pimozide</linktitle></a> 
3153c4606
< 								Oncology 
---
> 								Psychiatry 
3156c4609
< 								EGFR 
---
> 								CYP2D6 
3159c4612,4615
< 								Indications and Usage, Warnings and Precautions, Clinical Pharmacology, Clinical Studies 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Warnings, Precautions, Contraindications, Dosage and Administration 
3183c4639
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237474.htm target='_self'><linktitle>Panitumumab (2)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372827.htm target='_self'><linktitle>Ponatinib</linktitle></a> 
3190c4646
< 								KRAS 
---
> 								BCR/ABL1 
3193c4649,4652
< 								Indications and Usage, Clinical Pharmacology, Clinical Studies 
---
> 								Philadelphia chromosome (t(9;22)) positive, BCR –ABL T315I mutation 
> 						</td>
> 						<td>
> 								Indications and Usage, Warnings and Precautions, Adverse Reactions, Use in Specific Populations, Clinical Pharmacology, Clinical Studies 
3217c4676
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267371.htm target='_self'><linktitle>Pantoprazole</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm265500.htm target='_self'><linktitle>Prasugrel</linktitle></a> 
3221c4680
< 								Gastroenterology 
---
> 								Cardiology 
3227c4686,4689
< 								Clinical Pharmacology, Drug Interactions, Special Populations 
---
> 								CYP2C19 poor metabolizers 
> 						</td>
> 						<td>
> 								Use in Specific Populations, Clinical Pharmacology, Clinical Studies 
3251c4713
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267381.htm target='_self'><linktitle>Paroxetine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267386.htm target='_self'><linktitle>Pravastatin</linktitle></a> 
3255c4717
< 								Psychiatry 
---
> 								Endocrinology 
3258c4720
< 								CYP2D6 
---
> 								LDLR 
3261c4723,4726
< 								Clinical Pharmacology, Drug Interactions 
---
> 								Homozygous familial hypercholesterolemia and LDL receptor deficient 
> 						</td>
> 						<td>
> 								Clinical Studies, Use in Specific Populations 
3285c4750,4780
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm256296.htm target='_self'><linktitle>Peginterferon alfa-2b</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372830.htm target='_self'><linktitle>Primaquine</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Infectious Diseases 
> 						</td>
> 						<td>
> 								G6PD 
> 						</td>
> 						<td>
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Warnings and Precautions, Adverse Reactions 
> 						</td>
> 				</tr>
> 
> 				
> 
> 			
> 	
> 									
> 					  
> 									
> 
> 				
> 				
> 				
> 				
> 
> 		
3286a4782,4791
> 		    
> 				
> 		
> 				<tr>
> 						<td>
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237478.htm target='_self'><linktitle>Propafenone</linktitle></a> 
> 
> 						</td>
> 						<td>
> 								Cardiology 
3289c4794
< 								Antivirals 
---
> 								CYP2D6 
3292c4797
< 								IL28B 
---
> 								CYP2D6 poor metabolizers 
3319c4824
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267726.htm target='_self'><linktitle>Perphenazine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237480.htm target='_self'><linktitle>Propranolol</linktitle></a> 
3323c4828
< 								Psychiatry 
---
> 								Cardiology 
3329c4834,4837
< 								Clinical Pharmacology, Drug Interactions 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Precautions, Drug Interactions, Clinical Pharmacology 
3353c4861
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm309050.htm target='_self'><linktitle>Pertuzumab</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237483.htm target='_self'><linktitle>Protriptyline</linktitle></a> 
3357c4865,4868
< 								Oncology 
---
> 								Psychiatry 
> 						</td>
> 						<td>
> 								CYP2D6 
3360c4871
< 								ERBB2 (HER2) 
---
> 								CYP2D6 poor metabolizers 
3363c4874
< 								Indications and Usage, Warnings and Precautions, Adverse Reactions, Clinical Studies, Clinical Pharmacology 
---
> 								Precautions 
3387c4898
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm280936.htm target='_self'><linktitle>Phenytoin</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237501.htm target='_self'><linktitle>Quinidine</linktitle></a> 
3391c4902
< 								Neurology 
---
> 								Cardiology 
3394c4905
< 								HLA-B*1502 
---
> 								CYP2D6 
3397c4908,4911
< 								Warnings 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Precautions 
3421c4935
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm274355.htm target='_self'><linktitle>Pimozide</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm372833.htm target='_self'><linktitle>Quinine Sulfate</linktitle></a> 
3425c4939
< 								Psychiatry 
---
> 								Infectious Diseases 
3428c4942
< 								CYP2D6 
---
> 								G6PD 
3431c4945,4948
< 								Warnings, Precautions, Contraindications, Dosage and Administration 
---
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Contraindications, Patient Counseling Information 
3455c4972
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm265500.htm target='_self'><linktitle>Prasugrel</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237503.htm target='_self'><linktitle>Rabeprazole</linktitle></a> 
3459c4976
< 								Cardiovascular 
---
> 								Gastroenterology 
3465c4982,4985
< 								Use in Specific Populations, Clinical Pharmacology, Clinical Studies 
---
> 								CYP2C19 poor metabolizers 
> 						</td>
> 						<td>
> 								Drug Interactions, Clinical Pharmacology 
3489c5009
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267386.htm target='_self'><linktitle>Pravastatin</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237505.htm target='_self'><linktitle>Rasburicase</linktitle></a> 
3493c5013,5016
< 								Metabolic and Endocrinology 
---
> 								Oncology 
> 						</td>
> 						<td>
> 								G6PD 
3496c5019
< 								APOE2 
---
> 								G6PD deficient 
3499c5022
< 								Clinical Studies, Use in Specific Populations 
---
> 								Boxed Warning, Contraindications 
3523c5046
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237478.htm target='_self'><linktitle>Propafenone</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237517.htm target='_self'><linktitle>Rifampin, Isoniazid, and Pyrazinamide</linktitle></a> 
3527c5050
< 								Cardiovascular 
---
> 								Infectious Diseases 
3530c5053
< 								CYP2D6 
---
> 								NAT1-2 
3533c5056,5059
< 								Clinical Pharmacology 
---
> 								Slow inactivators 
> 						</td>
> 						<td>
> 								Adverse Reactions, Clinical Pharmacology 
3557c5083
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237480.htm target='_self'><linktitle>Propranolol</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237637.htm target='_self'><linktitle>Risperidone</linktitle></a> 
3561c5087
< 								Cardiovascular 
---
> 								Psychiatry 
3567c5093,5096
< 								Precautions, Drug Interactions, Clinical Pharmacology 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Drug Interactions, Clinical Pharmacology 
3591c5120
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237483.htm target='_self'><linktitle>Protriptyline</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm373048.htm target='_self'><linktitle>Rituximab</linktitle></a> 
3595c5124
< 								Psychiatry 
---
> 								Oncology 
3598c5127
< 								CYP2D6 
---
> 								MS4A1 
3601c5130,5133
< 								Precautions 
---
> 								CD20 positive 
> 						</td>
> 						<td>
> 								Indication and Usage, Clinical Pharmacology, Description, Precautions 
3625c5157
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237501.htm target='_self'><linktitle>Quinidine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm373049.htm target='_self'><linktitle>Rosuvastatin</linktitle></a> 
3629c5161
< 								Antiarrhythmics 
---
> 								Endocrinology 
3632c5164
< 								CYP2D6 
---
> 								LDLR 
3635c5167,5170
< 								Precautions 
---
> 								Homozygous and Heterozygous familial hypercholesterolemia 
> 						</td>
> 						<td>
> 								Indications and Usage, Dosage and Administration, Clinical Pharmacology, Clinical Studies 
3659c5194
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237503.htm target='_self'><linktitle>Rabeprazole</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm373052.htm target='_self'><linktitle>Sodium Nitrite</linktitle></a> 
3663c5198
< 								Gastroenterology 
---
> 								Antidotal Therapy 
3666c5201
< 								CYP2C19 
---
> 								G6PD 
3669c5204,5207
< 								Drug Interactions, Clinical Pharmacology 
---
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Warnings and Precautions 
3693c5231
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237505.htm target='_self'><linktitle>Rasburicase</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm373053.htm target='_self'><linktitle>Succimer</linktitle></a> 
3697c5235
< 								Oncology 
---
> 								Hematology 
3703c5241,5244
< 								Boxed Warning, Contraindications 
---
> 								G6PD deficient 
> 						</td>
> 						<td>
> 								Clinical Pharmacology 
3727c5268
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237517.htm target='_self'><linktitle>Rifampin, Isoniazid, and Pyrazinamide</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm373055.htm target='_self'><linktitle>Sulfamethoxazole and Trimethoprim</linktitle></a> 
3731c5272,5275
< 								Antiinfectives 
---
> 								Infectious Diseases 
> 						</td>
> 						<td>
> 								G6PD 
3734c5278
< 								NAT1; NAT2 
---
> 								G6PD deficient 
3737c5281
< 								Adverse Reactions, Clinical Pharmacology 
---
> 								Precautions 
3761c5305
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237637.htm target='_self'><linktitle>Risperidone</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237721.htm target='_self'><linktitle>Tamoxifen (1)</linktitle></a> 
3765c5309
< 								Psychiatry 
---
> 								Oncology 
3768c5312
< 								CYP2D6 
---
> 								ESR1, PGR 
3771c5315,5318
< 								Drug Interactions, Clinical Pharmacology 
---
> 								Hormone receptor positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Precautions, Medication Guide 
3795c5342
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237640.htm target='_self'><linktitle>Sodium Phenylacetate and Sodium Benzoate</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm320297.htm target='_self'><linktitle>Tamoxifen (2)</linktitle></a> 
3799c5346
< 								Gastroenterology 
---
> 								Oncology 
3802c5349
< 								UCD (NAGS; CPS; ASS; OTC; ASL; ARG) 
---
> 								F5 
3805c5352,5355
< 								Indications and Usage, Description, Clinical Pharmacology 
---
> 								Factor V Leiden carriers 
> 						</td>
> 						<td>
> 								Warnings 
3829c5379
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237643.htm target='_self'><linktitle>Sodium Phenylbutyrate</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm320298.htm target='_self'><linktitle>Tamoxifen (3)</linktitle></a> 
3833c5383,5386
< 								Gastroenterology 
---
> 								Oncology 
> 						</td>
> 						<td>
> 								F2 
3836c5389
< 								UCD (NAGS; CPS; ASS; OTC; ASL; ARG) 
---
> 								Prothrombin mutation G20210A 
3839c5392
< 								Indications and Usage, Dosage and Administration, Nutritional Management 
---
> 								Warnings 
3863c5416
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237721.htm target='_self'><linktitle>Tamoxifen (1)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm256307.htm target='_self'><linktitle>Telaprevir</linktitle></a> 
3867c5420
< 								Oncology 
---
> 								Infectious Diseases 
3870c5423
< 								ER 
---
> 								IFNL3 
3873c5426,5429
< 								Indications and Usage, Precautions, Medication Guide 
---
> 								IL28B rs12979860 T allele carriers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology 
3897c5453
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm320297.htm target='_self'><linktitle>Tamoxifen (2)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237723.htm target='_self'><linktitle>Terbinafine</linktitle></a> 
3901c5457
< 								Oncology 
---
> 								Infectious Diseases 
3904c5460
< 								Factor V Leiden (FV) 
---
> 								CYP2D6 
3907c5463,5466
< 								Warnings 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Drug Interactions 
3931c5490
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm320298.htm target='_self'><linktitle>Tamoxifen (3)</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237725.htm target='_self'><linktitle>Tetrabenazine</linktitle></a> 
3935c5494
< 								Oncology 
---
> 								Neurology 
3938c5497
< 								Prothrombin mutations (F2) 
---
> 								CYP2D6 
3941c5500,5503
< 								Warnings 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Dosage and Administration, Warnings, Clinical Pharmacology 
3965c5527
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm256307.htm target='_self'><linktitle>Telaprevir</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237732.htm target='_self'><linktitle>Thioguanine</linktitle></a> 
3969c5531
< 								Antivirals 
---
> 								Oncology 
3972c5534
< 								IL28B 
---
> 								TPMT 
3975c5537,5540
< 								Clinical Pharmacology 
---
> 								TPMT poor metabolizer 
> 						</td>
> 						<td>
> 								Dosage and Administration, Precautions, Warnings 
3999c5564
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237723.htm target='_self'><linktitle>Terbinafine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237921.htm target='_self'><linktitle>Thioridazine</linktitle></a> 
4003c5568
< 								Antifungals 
---
> 								Psychiatry 
4009c5574,5577
< 								Drug Interactions 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Precautions, Warnings, Contraindications 
4033c5601
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237725.htm target='_self'><linktitle>Tetrabenazine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm265501.htm target='_self'><linktitle>Ticagrelor</linktitle></a> 
4037c5605
< 								Neurology 
---
> 								Cardiology 
4040c5608
< 								CYP2D6 
---
> 								CYP2C19 
4043c5611,5614
< 								Dosage and Administration, Warnings, Clinical Pharmacology 
---
> 								CYP2C19 poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Studies 
4067c5638
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237732.htm target='_self'><linktitle>Thioguanine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237932.htm target='_self'><linktitle>Tolterodine</linktitle></a> 
4071c5642
< 								Oncology 
---
> 								Urology 
4074c5645
< 								TPMT 
---
> 								CYP2D6 
4077c5648,5651
< 								Dosage and Administration, Precautions, Warnings 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology, Drug Interactions, Warnings and Precautions 
4101c5675
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237921.htm target='_self'><linktitle>Thioridazine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm249747.htm target='_self'><linktitle>Tositumomab</linktitle></a> 
4105c5679
< 								Psychiatry 
---
> 								Oncology 
4108c5682
< 								CYP2D6 
---
> 								MS4A1 
4111c5685,5688
< 								Precautions, Warnings, Contraindications 
---
> 								CD20 antigen positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Clinical Pharmacology 
4135c5712
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm265501.htm target='_self'><linktitle>Ticagrelor</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237933.htm target='_self'><linktitle>Tramadol</linktitle></a> 
4139c5716
< 								Cardiovascular 
---
> 								Analgesic 
4142c5719
< 								CYP2C19 
---
> 								CYP2D6 
4145c5722,5725
< 								Clinical Studies 
---
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
> 								Clinical Pharmacology 
4169c5749
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237932.htm target='_self'><linktitle>Tolterodine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm373110.htm target='_self'><linktitle>Trametinib</linktitle></a> 
4173c5753
< 								Reproductive and Urologic 
---
> 								Oncology 
4176c5756
< 								CYP2D6 
---
> 								BRAF 
4179c5759,5762
< 								Clinical Pharmacology, Drug Interactions, Warnings and Precautions 
---
> 								BRAF V600E/K mutation positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Dosage and Administration, Adverse Reactions, Clinical Pharmacology, Clinical Studies, Patient Counseling Information 
4203c5786
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm249747.htm target='_self'><linktitle>Tositumomab</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm238027.htm target='_self'><linktitle>Trastuzumab</linktitle></a> 
4210c5793
< 								CD20 antigen 
---
> 								ERBB2 
4213c5796,5799
< 								Indications and Usage, Clinical Pharmacology 
---
> 								HER2 protein overexpression positive 
> 						</td>
> 						<td>
> 								Indications and Usage, Warnings and Precautions, Clinical Pharmacology, Clinical Studies 
4237c5823
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm237933.htm target='_self'><linktitle>Tramadol and Acetaminophen</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm238029.htm target='_self'><linktitle>Tretinoin</linktitle></a> 
4241c5827
< 								Analgesics 
---
> 								Oncology 
4244c5830
< 								CYP2D6 
---
> 								PML/RARA 
4247c5833,5836
< 								Clinical Pharmacology 
---
> 								PML/RARα (t(15;17)) gene expression positive 
> 						</td>
> 						<td>
> 								Clinical Studies, Indications and Usage, Warnings 
4271c5860
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm238027.htm target='_self'><linktitle>Trastuzumab</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267396.htm target='_self'><linktitle>Trimipramine</linktitle></a> 
4275c5864,5867
< 								Oncology 
---
> 								Psychiatry 
> 						</td>
> 						<td>
> 								CYP2D6 
4278c5870
< 								ERBB2 (HER2) 
---
> 								CYP2D6 poor metabolizers 
4281c5873
< 								Indications and Usage, Precautions, Clinical Pharmacology 
---
> 								Drug Interactions 
4305c5897
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm238029.htm target='_self'><linktitle>Tretinoin</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm373120.htm target='_self'><linktitle>Valproic Acid (1)</linktitle></a> 
4309c5901,5904
< 								Oncology 
---
> 								Neurology 
> 						</td>
> 						<td>
> 								POLG 
4312c5907
< 								PML/RARα 
---
> 								POLG mutation positive 
4315c5910
< 								Boxed Warning, Dosage and Administration, Precautions 
---
> 								Boxed Warning, Contraindications, Warnings and Precautions 
4339c5934
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm267396.htm target='_self'><linktitle>Trimipramine</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm238035.htm target='_self'><linktitle>Valproic Acid (2)</linktitle></a> 
4343c5938
< 								Psychiatry 
---
> 								Neurology 
4346c5941
< 								CYP2D6 
---
> 								NAGS, CPS1, ASS1, OTC, ASL, ABL2 
4349c5944,5947
< 								Drug Interactions 
---
> 								Urea cycle enzyme deficient 
> 						</td>
> 						<td>
> 								Contraindications, Warnings and Precautions, Adverse Reactions, Medication Guide 
4373c5971
< 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm238035.htm target='_self'><linktitle>Valproic Acid</linktitle></a> 
---
> 								<a href=/Drugs/ScienceResearch/ResearchAreas/Pharmacogenetics/ucm373121.htm target='_self'><linktitle>Velaglucerase Alfa</linktitle></a> 
4377c5975,5978
< 								Psychiatry 
---
> 								Metabolic Disorders 
> 						</td>
> 						<td>
> 								GBA 
4380c5981,5982
< 								UCD (NAGS; CPS; ASS; OTC; ASL; ARG) 
---
> 								Lysosomal glucocerebrosidase
> enzyme 
4383c5985
< 								Contraindications, Precautions, Adverse Reactions 
---
> 								Indication and Usage, Description,  Clinical Pharmacology, Clinical Studies 
4416a6019,6021
> 								BRAF V600E mutation positive 
> 						</td>
> 						<td>
4450a6056,6058
> 								CYP2D6 poor metabolizers 
> 						</td>
> 						<td>
4479c6087
< 								Antifungals 
---
> 								Infectious Diseases 
4484a6093,6095
> 								CYP219 intermediate or poor metabolizers 
> 						</td>
> 						<td>
4513c6124
< 								Hematology 
---
> 								Cardiology or Hematology 
4519c6130,6133
< 								Dosage and Administration, Precautions, Clinical Pharmacology 
---
> 								CYP2C9 intermediate or poor metabolizers 
> 						</td>
> 						<td>
> 								Dosage and Administration, Drug Interactions, Clinical Pharmacology 
4547c6161
< 								Hematology 
---
> 								Cardiology or Hematology 
4553c6167,6170
< 								Dosage and Administration, Precautions, Clinical Pharmacology 
---
> 								VKORC1 rs9923231 A allele carriers 
> 						</td>
> 						<td>
> 								Dosage and Administration, Clinical Pharmacology 
4573c6190,6192
< 					  			     
---
> 					  
> 							
> 					  				     
4580c6199,6201
< 					  			     
---
> 					  
> 							
> 					  				     
4587c6208,6210
< 					  			     
---
> 					  
> 							
> 					  				     
4594c6217,6219
< 					  			     
---
> 					  
> 							
> 					  				     
4601c6226,6228
< 					  			     
---
> 					  
> 							
> 					  				     
4608c6235,6237
< 					  			     
---
> 					  
> 							
> 					  				     
4615c6244,6246
< 					  			     
---
> 					  
> 							
> 					  				     
4622c6253,6255
< 					  			     
---
> 					  
> 							
> 					  				     
4629c6262,6264
< 					  			     
---
> 					  
> 							
> 					  				     
4645c6280,6281
<       <!--==== BEGIN Contact Us Box ==== -->	
---
> 			  <!--==== BEGIN Contact Us Box ==== -->
> 			  	
4657d6292
<  <!--==== END Contact Us Box ==== -->
4659,4672c6294,6307
<       <div class="clearfloat">
<         -
<       </div>
<     </div><!--==== END MIDDLE-COLUMN PAGE CONTENT ==== -->
<     
<     <div class="clearfloat">
<       -
<     </div>
<   </div>
<   </div><!--==== END MAIN CONTENT ==== --><!--/PAGEWATCH--><!--==== BEGIN PAGE FOOTER ==== --><!--==== END PAGE FOOTER ==== --><!--==== BEGIN pagetools Top ==== --><!--==== END pagetools Top ==== --><!--
<         ***********************
<         END CONSUMER HEALTH INFORMATION BY TOPIC: WRAPPER
<         ***********************
<       --><!--==== END OUTER PAGE WRAPPER ==== --><!--==== BEGIN CTP Disclaimer ==== -->
---
> 			  <!--==== END Contact Us Box ==== -->
> 			  <div class="clearfloat">
> 				-
> 			  </div>
> 			  </div><!--==== END MIDDLE-COLUMN PAGE CONTENT ==== -->
> 		<div class="clearfloat">
> 		  -
> 		</div>
> 	  </div>
> 	  </div><!--==== END MAIN CONTENT ==== --><!--/PAGEWATCH--><!--==== BEGIN PAGE FOOTER ==== --><!--==== END PAGE FOOTER ==== --><!--==== BEGIN pagetools Top ==== --><!--==== END pagetools Top ==== --><!--
> 			***********************
> 			END CONSUMER HEALTH INFORMATION BY TOPIC: WRAPPER
> 			***********************
> 		  --><!--==== END OUTER PAGE WRAPPER ==== --><!--==== BEGIN CTP Disclaimer ==== -->
4682a6318,6319
> 
> 
4686d6322
< 
4695c6331
< 				
---
> 
4706,4707c6342,6343
< 	<!-- <li>Page Last Updated: 06/19/2013</li> -->
< 	Page Last Updated: 06/19/2013
---
> 	<!-- <li>Page Last Updated: 03/11/2014</li> -->
> 	Page Last Updated: 03/11/2014
4711,4712c6347,6348
< <br/>
< 				Note: If you need help accessing information in different file formats, see <a href="/AboutFDA/AboutThisWebsite/WebsitePolicies/ViewingFiles/default.htm">Instructions for Downloading Viewers and Players</a>.
---
> 	<br/>
> 	Note: If you need help accessing information in different file formats, see <a href="/AboutFDA/AboutThisWebsite/WebsitePolicies/ViewingFiles/default.htm">Instructions for Downloading Viewers and Players</a>.		
4867c6503
<       
---
> 		  
